Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine in Children With Liver Disease

NCT02692066 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02692066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02692066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine in Children With Liver Disease
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Withdrawn
Start date
April 30, 2016
Completion date
April 30, 2016
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

transplants, varicella